U.S. FDA Approves Pfizer’s Biosimilar NIVESTYM™ (filgrastim-aafi)
Go back to U.S. FDA Approves Pfizer’s Biosimilar NIVESTYM™ (filgrastim-aafi)| Pfizer Inc. (NYSE: PFE) | Delayed: 29.02 +0.47 (1.65%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.55 | 52 Week High | $37.39 | |||
| Open | $28.79 | 52 Week Low | $28.25 | |||
| Day High | $29.09 | P/E | 17.59 | |||
| Day Low | $28.71 | EPS | $1.65 | |||
| Volume | 39,268,090 | |||||
